KRAS and lung cancer: The analysis of Kras copy number indicates the ratio between the HPNE/KrasG12V and HPNE cells is about 4 times (Fig. 1a), which is consistent with the recent finding that mutant Kras copy gains are positively selected during tumour progression in KPC lung cancer mouse model20, 21.